Compare Newegg Commerce Inc (NEGG) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newegg Commerce Inc vs Repligen Corporation Common Stock — how do they compare? Newegg Commerce Inc trades at $10.79 (market cap $222.53M), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is far larger — about 50.8× Newegg Commerce Inc's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Newegg Commerce Inc for 14 Days and Repligen Corporation Common Stock for 0 Days on average.
| NEGG | RGEN | |
|---|---|---|
Market Cap | $222.53M | $11.31B |
Volume | 29,798 | 1,216,919 |
Sector | Consumer Cyclical | Health |
52-Week High | $92.74 | $194.57 |
52-Week Low | $10.61 | $102.87 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | $192.77M | $11.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NEGG trades at $11.13, down 1.94% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $4.88M in 2025, though revenue grew to $1.44B and net income margin improved to -0.34%. Recent news highlights partnerships with Western Digital and Hewlett Packard Enterprise to support AI and IT infrastructure, while insider selling has contributed to negative sentiment.
The outlook is mixed: analyst consensus is a Buy with a $7.75 price target, but the stock faces risks from volatile cash flows, high liabilities, and competitive pressures. Near-term catalysts include the Q3 2026 earnings report and execution on new business initiatives, but investors should weigh improving profitability against persistent operational challenges.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
